1. Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly
- Author
-
Xiaoyu Zhan, Xingyu Bi, Yaoqin Wang, Junmei Fan, Yong Mao, Yuan Yuan, Zhiping Zhang, Suming Xu, Yanbing Cheng, Pengfei Zhu, Xueqing Wu, Huixia Bi, and Lei Zhang
- Subjects
Adult ,Male ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,Genetic counseling ,Disease ,030105 genetics & heredity ,Compound heterozygosity ,03 medical and health sciences ,Cystic kidney disease ,Pregnancy ,Genetics ,medicine ,Humans ,Genetic Testing ,Preimplantation Diagnosis ,Genetics (clinical) ,Genetic testing ,medicine.diagnostic_test ,business.industry ,Membrane Proteins ,Kidney Diseases, Cystic ,medicine.disease ,030104 developmental biology ,Mutation ,Mutation (genetic algorithm) ,Female ,Carrier Proteins ,business ,Hydrocephalus ,Kidney disease ,Ventriculomegaly - Abstract
Ventriculomegaly with cystic kidney disease (VMCKD) is a rare and severe disorder characterized by cerebral ventriculomegaly, greatly elevated maternal serum alpha-fetoprotein (MSAFP) or amniotic fluid alpha-fetoprotein (AFAFP) levels and kidney disease similar to Finnish congenital nephrosis. Recessive mutations in the CRB2 (NM_173689) gene have been shown to cause the syndrome. Here, we described a nonconsanguineous Chinese family with two fetuses affected with VMCKD. A novel compound heterozygous mutation was identified in the CRB2 gene with co-segregation. One mutation [c.1960G>C (p.A654P)] was inherited from the father, while another mutation [c.3078_c.3093delGGCGCGGCCCCGGCCC (p.L1026Lfs*110)] was inherited from the mother. Preimplantation genetic testing for monogenic disease (PGT-M) was performed for the carrier couple with full informed consent and successfully blocked the inheritance of the disease. Our study has important implications on molecular diagnosis and genetic counseling for VMCKD and extends the mutation spectrum in CRB2 gene.
- Published
- 2020
- Full Text
- View/download PDF